Growth Metrics

Organogenesis Holdings (ORGO) Long-Term Investments (2016 - 2018)

Historic Long-Term Investments for Organogenesis Holdings (ORGO) over the last 3 years, with Q3 2018 value amounting to $316.3 million.

  • Organogenesis Holdings' Long-Term Investments rose 148.44% to $316.3 million in Q3 2018 from the same period last year, while for Sep 2018 it was $316.3 million, marking a year-over-year increase of 148.44%. This contributed to the annual value of $312.5 million for FY2017, which is 80.58% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Long-Term Investments of $316.3 million as of Q3 2018, which was up 148.44% from $314.8 million recorded in Q2 2018.
  • Over the past 5 years, Organogenesis Holdings' Long-Term Investments peaked at $316.3 million during Q3 2018, and registered a low of $310.0 million during Q4 2016.
  • Its 3-year average for Long-Term Investments is $312.4 million, with a median of $312.1 million in 2017.
  • Per our database at Business Quant, Organogenesis Holdings' Long-Term Investments soared by 80.58% in 2017 and then soared by 148.44% in 2018.
  • Organogenesis Holdings' Long-Term Investments (Quarter) stood at $310.0 million in 2016, then increased by 0.81% to $312.5 million in 2017, then grew by 1.21% to $316.3 million in 2018.
  • Its Long-Term Investments was $316.3 million in Q3 2018, compared to $314.8 million in Q2 2018 and $313.2 million in Q1 2018.